| scholarly article | Q13442814 |
| P2093 | author name string | Alfred N Fonteh | |
| Michael G Harrington | |||
| Xianghong Arakaki | |||
| Abby J Chiang | |||
| Sarah P Edminster | |||
| Matthew Cipolla | |||
| P2860 | cites work | Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models | Q21135583 |
| Identification of phospholipid scramblase 1 as a novel interacting molecule with beta -secretase (beta -site amyloid precursor protein (APP) cleaving enzyme (BACE)) | Q24294704 | ||
| Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake | Q24646913 | ||
| A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
| Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease | Q26766462 | ||
| Roles of resolvins in the resolution of acute inflammation | Q28244502 | ||
| Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome | Q28387661 | ||
| Imbalance in fatty-acid-chain length of gangliosides triggers Alzheimer amyloid deposition in the precuneus | Q28544853 | ||
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| Reactive oxygen species regulate F-actin dynamics in neuronal growth cones and neurite outgrowth | Q30497525 | ||
| Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease | Q46819526 | ||
| CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival | Q46878198 | ||
| Contribution of brain glucose and ketone bodies to oxidative metabolism | Q47282635 | ||
| Dendritic spines provide cognitive resilience against Alzheimer's disease | Q47619556 | ||
| Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study | Q48272484 | ||
| Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain | Q48382879 | ||
| Plasmalogen-selective phospholipase A2 and its involvement in Alzheimer's disease | Q48437322 | ||
| Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice | Q48502367 | ||
| Gangliosides determine the amyloid pathology of Alzheimer's disease | Q48528799 | ||
| Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain | Q49122730 | ||
| Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease | Q49506046 | ||
| Apolipoprotein E genotyping method by real time PCR, a fast and cost-effective alternative to the TaqMan and FRET assays. | Q50588994 | ||
| Omega-6 to omega-3 fatty acid ratio and higher-order cognitive functions in 7- to 9-y-olds: a cross-sectional study. | Q50735797 | ||
| The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases. | Q53153446 | ||
| Alzheimer's disease: it's irreversible but not untreatable | Q53200714 | ||
| Cox-2 expression, PGE(2) and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice. | Q53310684 | ||
| Liposome-incorporated DHA increases neuronal survival by enhancing non-amyloidogenic APP processing | Q54636930 | ||
| MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. | Q55518708 | ||
| Oxidative Stress Levels in the Brain Are Determined by Post-Mortem Interval and Ante-Mortem Vitamin C State but Not Alzheimer's Disease Status. | Q64988983 | ||
| Quantitative release of fatty acids from lipids by a simple hydrolysis procedure | Q71073199 | ||
| Cholesterol-induced astrocyte activation is associated with increased amyloid precursor protein expression and processing | Q85417338 | ||
| Localisation of Formyl-Peptide Receptor 2 in the Rat Central Nervous System and Its Role in Axonal and Dendritic Outgrowth | Q89287054 | ||
| Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention | Q89391644 | ||
| The Role of Cognitive Reserve in Alzheimer's Disease and Aging: A Multi-Modal Imaging Review | Q90211040 | ||
| Palmitate-Induced SREBP1 Expression and Activation Underlies the Increased BACE 1 Activity and Amyloid Beta Genesis | Q90656244 | ||
| The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease | Q91030552 | ||
| Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis | Q91395183 | ||
| Characterization of the unique In Vitro effects of unsaturated fatty acids on the formation of amyloid β fibrils | Q91768531 | ||
| Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain | Q92603401 | ||
| Oral Ketone Supplementation Acutely Increases Markers of NLRP3 Inflammasome Activation in Human Monocytes | Q92621735 | ||
| A Single Injection of Docosahexaenoic Acid Induces a Pro-Resolving Lipid Mediator Profile in the Injured Tissue and a Long-Lasting Reduction in Neurological Deficit after Traumatic Brain Injury in Mice | Q93135654 | ||
| Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes | Q33564624 | ||
| Oxidative stress in the progression of Alzheimer disease in the frontal cortex | Q33680790 | ||
| Elevated oxidative stress in models of normal brain aging and Alzheimer's disease | Q33781604 | ||
| Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease | Q33793583 | ||
| CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's Disease | Q33896118 | ||
| CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease | Q34113001 | ||
| Metabolic syndrome as a risk factor for neurological disorders. | Q34224030 | ||
| Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study | Q35048396 | ||
| Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. | Q35776495 | ||
| Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage. | Q35823788 | ||
| Fatty acid oxidation in the pathogenesis of Alzheimer's disease | Q36108432 | ||
| Palmitoylated APP Forms Dimers, Cleaved by BACE1. | Q36201112 | ||
| Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial | Q36532732 | ||
| Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model | Q36688749 | ||
| Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology | Q36807757 | ||
| Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts | Q37032450 | ||
| Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease | Q37141206 | ||
| Docosahexaenoic acid and the aging brain | Q37152345 | ||
| Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease. | Q37163086 | ||
| The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid | Q37351866 | ||
| Oxidative stress in Alzheimer disease: a possibility for prevention | Q37731603 | ||
| Phospholipase A2 and arachidonic acid in Alzheimer's disease | Q37765687 | ||
| Aging, the metabolic syndrome, and ischemic stroke: redefining the approach for studying the blood-brain barrier in a complex neurological disease | Q38259314 | ||
| Lipidomics analysis of essential fatty acids in macrophages | Q38439774 | ||
| Dietary DHA and health: cognitive function ageing. | Q39014590 | ||
| A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden | Q39036146 | ||
| Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms | Q39591498 | ||
| Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease. | Q40090661 | ||
| EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer's patients | Q42501513 | ||
| MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis | Q42696088 | ||
| Impacts of membrane biophysics in Alzheimer's disease: from amyloid precursor protein processing to aβ Peptide-induced membrane changes | Q42726604 | ||
| Beta-secretase processing of the Alzheimer's amyloid protein precursor (APP). | Q44591004 | ||
| Involvement of arachidonic acid cascade in working memory impairment induced by interleukin-1 beta | Q44864736 | ||
| The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study | Q44957795 | ||
| Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and up-regulates cytoskeletal protein expression. | Q46021372 | ||
| Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities | Q46125319 | ||
| Fatty aspirin: a new perspective in the prevention of dementia of Alzheimer's type? | Q46316239 | ||
| Oxidized Docosahexaenoic Acid Species and Lipid Peroxidation Products Increase Amyloidogenic Amyloid Precursor Protein Processing | Q46627439 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | fatty acid composition | Q128903645 |
| P304 | page(s) | 83 | |
| P577 | publication date | 2020-02-14 | |
| P1433 | published in | Frontiers in Physiology | Q2434141 |
| P1476 | title | Polyunsaturated Fatty Acid Composition of Cerebrospinal Fluid Fractions Shows Their Contribution to Cognitive Resilience of a Pre-symptomatic Alzheimer's Disease Cohort | |
| P478 | volume | 11 |
Search more.